These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22436084)

  • 21. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
    Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
    Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
    Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intranasal chitosan-g-HPβCD nanoparticles of efavirenz for the CNS targeting.
    Belgamwar A; Khan S; Yeole P
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):374-386. PubMed ID: 28423949
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bio-fabrication and statistical optimization of polysorbate 80 coated chitosan nanoparticles of tapentadol hydrochloride for central antinociceptive effect: in vitro-in vivo studies.
    Patil GB; Surana SJ
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):505-514. PubMed ID: 27017892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane.
    Singh KH; Shinde UA
    Pharmazie; 2011 Aug; 66(8):594-9. PubMed ID: 21901982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic variables of medium molecular weight cross linked chitosan nanoparticles to enhance the bioavailability of 5-fluorouracil and reduce the acute oral toxicity.
    Sethi A; Ahmad M; Huma T; Ahmad W
    Drug Deliv; 2021 Dec; 28(1):1569-1584. PubMed ID: 34291722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
    Brar V; Kaur G
    Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
    Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
    Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery.
    Su FY; Lin KJ; Sonaje K; Wey SP; Yen TC; Ho YC; Panda N; Chuang EY; Maiti B; Sung HW
    Biomaterials; 2012 Mar; 33(9):2801-11. PubMed ID: 22243802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and Characterization of Mucoadhesive Buccal Nanoparticles Using Chitosan and Dextran Sulfate.
    Suh JW; Lee JS; Ko S; Lee HG
    J Agric Food Chem; 2016 Jul; 64(26):5384-8. PubMed ID: 27222213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thiomer nanoparticles: stabilization via covalent cross-linking.
    Barthelmes J; Dünnhaupt S; Hombach J; Bernkop-Schnürch A
    Drug Deliv; 2011 Nov; 18(8):613-9. PubMed ID: 22111974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketoconazole encapsulated in chitosan-gellan gum nanocomplexes exhibits prolonged antifungal activity.
    Kumar S; Kaur P; Bernela M; Rani R; Thakur R
    Int J Biol Macromol; 2016 Dec; 93(Pt A):988-994. PubMed ID: 27659003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan-TPP nanoparticles stabilized by poloxamer for controlling the release and enhancing the bioavailability of doxazosin mesylate:
    Aljaeid BM; El-Say KM; Hosny KM
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1130-1139. PubMed ID: 30884977
    [No Abstract]   [Full Text] [Related]  

  • 35. Development, characterization, and in vivo assessment of mucoadhesive nanoparticles containing fluconazole for the local treatment of oral candidiasis.
    Rençber S; Karavana SY; Yılmaz FF; Eraç B; Nenni M; Özbal S; Pekçetin Ç; Gurer-Orhan H; Hoşgör-Limoncu M; Güneri P; Ertan G
    Int J Nanomedicine; 2016; 11():2641-53. PubMed ID: 27358561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation and evaluation of stomach-specific amoxicillin-loaded carbopol-934P mucoadhesive microspheres for anti-Helicobacter pylori therapy.
    Patel JK; Chavda JR
    J Microencapsul; 2009 Jun; 26(4):365-76. PubMed ID: 18720199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
    Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
    Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation development of albumin based theragnostic nanoparticles as a potential delivery system for tumor targeting.
    Kolluru LP; Rizvi SA; D'Souza M; D'Souza MJ
    J Drug Target; 2013 Jan; 21(1):77-86. PubMed ID: 23036042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rutin-encapsulated chitosan nanoparticles targeted to the brain in the treatment of Cerebral Ischemia.
    Ahmad N; Ahmad R; Naqvi AA; Alam MA; Ashafaq M; Samim M; Iqbal Z; Ahmad FJ
    Int J Biol Macromol; 2016 Oct; 91():640-55. PubMed ID: 27264648
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.